US › Healthcare

Cronos Group Inc (CRON)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$2.81-0.71%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$44.6M
Revenue YoY
+38.2%
Net profit
$13.6M
Profit YoY
+121.5%
EPS
$0.05
EPS estimate
$0.01
Net margin
30.4%

EPS came in at 0.05 against a street estimate of 0.01 — a beat of 400.0%.

Key statistics

Market cap
$1.06B
P/E
0.0
Forward P/E
28.2
P/B
0.99
Book value
$2.85
EPS (TTM)
$0.00
52-week high
$3.43
52-week low
$2.00
50-day MA
$2.76
200-day MA
$2.64
Beta
1.24

Analyst view

Analysts rate Cronos Group Inc a hold (2 buy, 2 hold, 1 sell out of 5) with an average price target of $2.54.

Shareholding

Insiders
48.85%
Institutions
15.70%

Largest institutional holders

FundStake
Chescapmanager LLC2.13%
D. E. Shaw & Co LP2.04%
Pillsbury Lake Capital LLC1.13%
Tidal Investments LLC.1.08%
Dimensional Fund Advisors, Inc.0.72%
Renaissance Technologies Corp0.54%
Springbok Capital Management, LLC0.40%
CIBC World Markets Inc.0.36%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Cronos Group Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.